CGEM Insider Trading

Insider Ownership Percentage: 6.07%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $3,544,211.52

Cullinan Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Cullinan Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Cullinan Therapeutics Share Price & Price History

Current Price: $11.85
Price Change: Price Increase of +0.1 (0.85%)
As of 12/16/2024 02:36 PM ET

This chart shows the closing price history over time for CGEM up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Cullinan Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/5/2024Jennifer MichaelsonInsiderSell8,000$15.64$125,120.00107,942View SEC Filing Icon  
9/5/2024Jennifer MichaelsonInsiderSell8,000$18.09$144,720.00115,942View SEC Filing Icon  
7/5/2024Jennifer MichaelsonInsiderSell8,000$16.33$130,640.00123,942View SEC Filing Icon  
5/6/2024Jennifer MichaelsonInsiderSell58,000$28.07$1,628,060.00129,582View SEC Filing Icon  
2/1/2024Corrine SavillInsiderSell40,000$16.18$647,200.00165,990View SEC Filing Icon  
1/29/2024Corrine SavillInsiderSell40,000$14.09$563,600.00165,990View SEC Filing Icon  
1/22/2024Corrine SavillInsiderSell18,684$12.14$226,823.76165,990View SEC Filing Icon  
12/26/2023Nadim AhmedCEOSell4,272$9.24$39,473.28111,550View SEC Filing Icon  
12/21/2023Jeffrey Alan JonesInsiderSell1,860$8.50$15,810.0056,191View SEC Filing Icon  
12/21/2023Jeffrey TrigilioCFOSell1,920$8.50$16,320.0083,919View SEC Filing Icon  
12/18/2023Jeffrey Alan JonesInsiderSell386$8.22$3,172.9258,051View SEC Filing Icon  
12/18/2023Jeffrey TrigilioCFOSell398$8.22$3,271.5685,839View SEC Filing Icon  
12/12/2023Jeffrey TrigilioCFOSell1,926$7.81$15,042.0686,237View SEC Filing Icon  
12/12/2023Jennifer MichaelsonInsiderSell1,068$7.81$8,341.0888,965View SEC Filing Icon  
6/28/2023Nadim AhmedCEOSell759$11.40$8,652.60115,822View SEC Filing Icon  
6/20/2023Jeffrey Alan JonesInsiderSell387$12.94$5,007.7858,437View SEC Filing Icon  
6/20/2023Jeffrey TrigilioCFOSell399$12.94$5,163.0685,823View SEC Filing Icon  
6/12/2023Jeffrey TrigilioCFOSell319$13.11$4,182.0986,222View SEC Filing Icon  
6/12/2023Jennifer MichaelsonInsiderSell176$13.11$2,307.3690,271View SEC Filing Icon  
6/6/2023Jennifer MichaelsonInsiderSell11,900$12.31$146,489.0090,447View SEC Filing Icon  
5/23/2023Nadim AhmedCEOSell707$9.15$6,469.05116,581View SEC Filing Icon  
5/18/2023Jeffrey TrigilioCFOSell399$8.76$3,495.2486,541View SEC Filing Icon  
5/18/2023Jennifer MichaelsonInsiderSell239$8.76$2,093.6490,447View SEC Filing Icon  
5/12/2023Jeffrey TrigilioCFOSell347$8.78$3,046.6686,940View SEC Filing Icon  
5/12/2023Jennifer MichaelsonInsiderSell193$8.78$1,694.5490,686View SEC Filing Icon  
4/25/2023Nadim AhmedCEOSell716$10.59$7,582.44117,288View SEC Filing Icon  
4/18/2023Jeffrey Alan JonesInsiderSell392$10.71$4,198.3259,218View SEC Filing Icon  
4/18/2023Jeffrey TrigilioCFOSell398$10.71$4,262.5887,287View SEC Filing Icon  
4/12/2023Jeffrey TrigilioCFOSell318$10.22$3,249.9687,685View SEC Filing Icon  
4/12/2023Jennifer MichaelsonInsiderSell176$10.22$1,798.7291,117View SEC Filing Icon  
3/23/2023Nadim AhmedCEOSell706$10.51$7,420.06118,004View SEC Filing Icon  
3/20/2023Jeffrey Alan JonesInsiderSell390$11.32$4,414.8059,610View SEC Filing Icon  
3/20/2023Jeffrey TrigilioCFOSell399$11.32$4,516.6888,003View SEC Filing Icon  
11/25/2022Jennifer MichaelsonInsiderSell4,000$13.30$53,200.0053,031View SEC Filing Icon  
9/27/2022Jennifer MichaelsonInsiderSell4,000$12.40$49,600.0053,031View SEC Filing Icon  
8/4/2022Vision Scs F2Major ShareholderSell25,989$14.31$371,902.591,255,963View SEC Filing Icon  
8/2/2022Vision Scs F2Major ShareholderSell4,792$14.10$67,567.201,301,081View SEC Filing Icon  
7/25/2022Jennifer MichaelsonInsiderSell8,000$14.51$116,080.0053,031View SEC Filing Icon  
7/18/2022Corrine SavillInsiderSell5,042$15.06$75,932.52164,573View SEC Filing Icon  
7/11/2022Corrine SavillInsiderSell40,000$13.33$533,200.00169,615View SEC Filing Icon  
6/23/2022Bioscience I 2017 Ltd F2Major ShareholderSell29,631$13.00$385,203.00537,392View SEC Filing Icon  
6/21/2022Bioscience I 2017 Ltd F2Major ShareholderSell22,319$12.77$285,013.63616,976View SEC Filing Icon  
6/6/2022Nadim AhmedCEOBuy8,090$12.40$100,316.008,090View SEC Filing Icon  
6/1/2022Bvf Partners L P/IlMajor ShareholderBuy751,396$11.00$8,265,356.004,058,854View SEC Filing Icon  
5/16/2022Vision Scs F2Major ShareholderSell35,158$11.23$394,824.341,305,873View SEC Filing Icon  
5/12/2022Vision Scs F2Major ShareholderSell264,072$9.25$2,442,666.001,460,539View SEC Filing Icon  
4/1/2022Bvf Partners L P/IlMajor ShareholderBuy276,000$10.75$2,967,000.00301,671View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Cullinan Therapeutics (NASDAQ:CGEM)

86.31% of Cullinan Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at CGEM by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Cullinan Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/27/2024Franklin Resources Inc.2,191,262$35.56M0.0%-10.3%3.763%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC1,208,421$20.23M0.0%+23.8%2.075%Search for SEC Filing on Google Icon
11/15/2024Barclays PLC248,614$4.16M0.0%+26.0%0.427%Search for SEC Filing on Google Icon
11/15/2024Y Intercept Hong Kong Ltd25,369$0.43M0.0%+40.7%0.044%Search for SEC Filing on Google Icon
11/15/2024Wellington Management Group LLP106,025$1.78M0.0%+47.1%0.182%Search for SEC Filing on Google Icon
11/15/2024Sphera Funds Management LTD.185,871$3.11M0.5%N/A0.319%Search for SEC Filing on Google Icon
11/15/2024State Street Corp2,337,222$39.13M0.0%+20.4%4.014%Search for SEC Filing on Google Icon
11/15/2024RTW Investments LP1,705,960$28.56M0.4%+62.1%2.930%Search for SEC Filing on Google Icon
11/15/2024Patient Square Capital LP824,705$13.81M5.1%N/A1.416%Search for SEC Filing on Google Icon
11/15/2024HighVista Strategies LLC31,893$0.53M0.2%N/A0.055%Search for SEC Filing on Google Icon
11/15/2024Holocene Advisors LP1,533,579$25.67M0.1%+16.5%2.634%Search for SEC Filing on Google Icon
11/14/2024PFM Health Sciences LP182,810$3.06M0.2%-38.2%0.314%Search for SEC Filing on Google Icon
11/14/2024Braidwell LP1,176,173$19.69M0.6%+567.6%2.020%Search for SEC Filing on Google Icon
11/14/2024Verition Fund Management LLC36,624$0.61M0.0%N/A0.063%Search for SEC Filing on Google Icon
11/14/2024Walleye Capital LLC328,417$5.50M0.0%+253.6%0.564%Search for SEC Filing on Google Icon
11/14/2024Martingale Asset Management L P32,842$0.55M0.0%+134.2%0.056%Search for SEC Filing on Google Icon
11/14/2024UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC70,911$1.19M0.0%+3.5%0.122%Search for SEC Filing on Google Icon
11/14/2024MetLife Investment Management LLC29,841$0.50M0.0%+31.3%0.051%Search for SEC Filing on Google Icon
11/13/2024FMR LLC20,360$0.34M0.0%+2,898.5%0.035%Search for SEC Filing on Google Icon
11/13/2024The Manufacturers Life Insurance Company25,538$0.43M0.0%+68.3%0.044%Search for SEC Filing on Google Icon
11/12/2024Charles Schwab Investment Management Inc.423,959$7.10M0.0%+14.4%0.731%Search for SEC Filing on Google Icon
11/9/2024Intech Investment Management LLC17,487$0.29M0.0%N/A0.030%Search for SEC Filing on Google Icon
11/7/2024Quest Partners LLC20,404$0.34M0.0%+900.7%0.035%Search for SEC Filing on Google Icon
10/30/2024Amalgamated Bank1,768$30K0.0%+97.3%0.003%Search for SEC Filing on Google Icon
10/29/2024Harbor Capital Advisors Inc.21,362$0.36M0.0%+22.2%0.037%Search for SEC Filing on Google Icon
10/25/2024China Universal Asset Management Co. Ltd.11,151$0.19M0.0%+64.7%0.019%Search for SEC Filing on Google Icon
10/23/2024Assenagon Asset Management S.A.135,036$2.26M0.0%+18.3%0.234%Search for SEC Filing on Google Icon
10/10/2024Exchange Traded Concepts LLC9,891$0.17M0.0%-23.0%0.017%Search for SEC Filing on Google Icon
10/3/2024SG Americas Securities LLC15,057$0.25M0.0%-82.3%0.026%Search for SEC Filing on Google Icon
8/16/2024Perceptive Advisors LLC749,916$13.08M0.3%N/A1.301%Search for SEC Filing on Google Icon
8/16/2024Algert Global LLC39,884$0.70M0.0%-49.9%0.069%Search for SEC Filing on Google Icon
8/15/2024Blue Owl Capital Holdings LP2,049,172$35.74M10.0%-29.9%3.555%Search for SEC Filing on Google Icon
8/15/2024Lynx1 Capital Management LP377,323$6.58M2.4%N/A0.655%Search for SEC Filing on Google Icon
8/15/2024The Manufacturers Life Insurance Company15,175$0.27M0.0%+40.7%0.026%Search for SEC Filing on Google Icon
8/15/2024Deerfield Management Company L.P. Series C3,280,237$57.21M1.0%+188.1%5.691%Search for SEC Filing on Google Icon
8/15/2024Affinity Asset Advisors LLC263,817$4.60M0.5%+2.0%0.458%Search for SEC Filing on Google Icon
8/14/2024Squarepoint Ops LLC10,669$0.19M0.0%N/A0.019%Search for SEC Filing on Google Icon
8/14/2024Marshall Wace LLP1,184,037$20.65M0.0%+2,416.9%2.054%Search for SEC Filing on Google Icon
8/14/2024Profund Advisors LLC19,352$0.34M0.0%+26.8%0.034%Search for SEC Filing on Google Icon
8/13/2024Ensign Peak Advisors Inc148,773$2.60M0.0%N/A0.258%Search for SEC Filing on Google Icon
8/12/2024E Fund Management Co. Ltd.74,827$1.31M0.1%N/A0.130%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC421,708$7.36M0.0%+31.3%0.732%Search for SEC Filing on Google Icon
8/9/2024Dimensional Fund Advisors LP759,760$13.25M0.0%-23.5%1.318%Search for SEC Filing on Google Icon
8/8/2024Cornercap Investment Counsel Inc.11,491$0.20M0.0%-38.2%0.020%Search for SEC Filing on Google Icon
8/8/2024American Century Companies Inc.76,018$1.33M0.0%+32.9%0.132%Search for SEC Filing on Google Icon
8/6/2024Quest Partners LLC2,039$36K0.0%-76.5%0.004%Search for SEC Filing on Google Icon
8/5/2024Arizona State Retirement System10,460$0.18M0.0%N/A0.018%Search for SEC Filing on Google Icon
8/1/2024Rhumbline Advisers54,351$0.95M0.0%+16.4%0.094%Search for SEC Filing on Google Icon
7/29/2024Zurcher Kantonalbank Zurich Cantonalbank8,883$0.16M0.0%+73.3%0.015%Search for SEC Filing on Google Icon
7/26/2024Bank of New York Mellon Corp137,997$2.41M0.0%+46.4%0.239%Search for SEC Filing on Google Icon
7/18/2024Assenagon Asset Management S.A.114,195$1.99M0.0%N/A0.198%Search for SEC Filing on Google Icon
7/12/2024SG Americas Securities LLC85,172$1.49M0.0%+757.2%0.148%Search for SEC Filing on Google Icon
7/9/2024Harbor Capital Advisors Inc.17,481$0.31M0.0%+39.4%0.030%Search for SEC Filing on Google Icon
5/16/2024California State Teachers Retirement System23,752$0.41M0.0%-5.7%0.055%Search for SEC Filing on Google Icon
5/16/2024Kennedy Capital Management LLC84,234$1.44M0.0%-47.4%0.196%Search for SEC Filing on Google Icon
5/15/2024Price T Rowe Associates Inc. MD22,842$0.39M0.0%+3.7%0.053%Search for SEC Filing on Google Icon
5/15/2024Affinity Asset Advisors LLC258,588$4.41M0.6%-13.8%0.600%Search for SEC Filing on Google Icon
5/14/2024American International Group Inc.12,742$0.22M0.0%-99.0%0.030%Search for SEC Filing on Google Icon
5/13/2024Ameritas Investment Partners Inc.2,599$44K0.0%+31.0%0.006%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.1,774,345$30.24M0.0%+0.2%4.120%Search for SEC Filing on Google Icon
5/7/2024SG Americas Securities LLC9,936$0.17M0.0%-31.2%0.023%Search for SEC Filing on Google Icon
5/1/2024Mirae Asset Global Investments Co. Ltd.17,269$0.29M0.0%+22.2%0.040%Search for SEC Filing on Google Icon
4/29/2024China Universal Asset Management Co. Ltd.8,996$0.15M0.0%+81.6%0.021%Search for SEC Filing on Google Icon
2/28/2024American International Group Inc.1,236,564$12.60M0.1%+0.1%2.891%Search for SEC Filing on Google Icon
2/15/2024Parkman Healthcare Partners LLC529,877$5.40M0.8%+20.8%1.239%Search for SEC Filing on Google Icon
2/14/2024Braidwell LP1,240,865$12.64M0.5%-35.0%2.901%Search for SEC Filing on Google Icon
2/13/2024American International Group Inc.1,236,564$12.60M0.1%+0.1%2.891%Search for SEC Filing on Google Icon
2/13/2024Tower Research Capital LLC TRC10,234$0.10M0.0%-33.5%0.024%Search for SEC Filing on Google Icon
2/13/2024Affinity Asset Advisors LLC300,000$3.06M0.6%N/A0.701%Search for SEC Filing on Google Icon
2/13/2024NEOS Investment Management LLC15,906$0.16M0.0%N/A0.037%Search for SEC Filing on Google Icon
2/9/2024Franklin Resources Inc.3,281,280$33.44M0.0%+13.5%7.670%Search for SEC Filing on Google Icon
2/9/2024Quest Partners LLC17,601$0.18M0.0%N/A0.041%Search for SEC Filing on Google Icon
2/9/2024Trexquant Investment LP34,955$0.36M0.0%N/A0.082%Search for SEC Filing on Google Icon
2/6/2024Swiss National Bank46,300$0.47M0.0%+19.9%0.108%Search for SEC Filing on Google Icon
2/6/2024New York Life Investment Management LLC33,759$0.34M0.0%-3.0%0.079%Search for SEC Filing on Google Icon
2/2/2024Bailard Inc.10,800$0.11M0.0%N/A0.025%Search for SEC Filing on Google Icon
1/30/2024Vontobel Holding Ltd.10,000$0.10M0.0%N/A0.023%Search for SEC Filing on Google Icon
1/24/2024China Universal Asset Management Co. Ltd.4,954$50K0.0%+352.4%0.012%Search for SEC Filing on Google Icon
1/12/2024SG Americas Securities LLC14,449$0.15M0.0%+12.3%0.034%Search for SEC Filing on Google Icon
1/5/2024Exchange Traded Concepts LLC14,076$0.14M0.0%+34.0%0.033%Search for SEC Filing on Google Icon
12/6/2023Citigroup Inc.23,534$0.21M0.0%+186.1%0.055%Search for SEC Filing on Google Icon
11/15/2023Annandale Capital LLC12,000$0.11M0.0%+20.0%0.028%Search for SEC Filing on Google Icon
11/15/2023Kennedy Capital Management LLC489,446$4.43M0.1%-9.7%1.144%Search for SEC Filing on Google Icon
11/14/2023Schonfeld Strategic Advisors LLC121,800$1.10M0.0%+15.9%0.285%Search for SEC Filing on Google Icon
11/13/2023Algert Global LLC16,540$0.15M0.0%N/A0.039%Search for SEC Filing on Google Icon
11/13/2023Federated Hermes Inc.20,000$0.18M0.0%N/A0.047%Search for SEC Filing on Google Icon
11/13/2023Hsbc Holdings PLC21,875$0.20M0.0%N/A0.051%Search for SEC Filing on Google Icon
11/8/2023New York Life Investment Management LLC34,804$0.32M0.0%-13.6%0.081%Search for SEC Filing on Google Icon
11/7/2023Barclays PLC53,393$0.48M0.0%+145.6%0.125%Search for SEC Filing on Google Icon
11/6/2023Assenagon Asset Management S.A.609,106$5.51M0.0%+380.1%1.425%Search for SEC Filing on Google Icon
10/27/2023Allspring Global Investments Holdings LLC7,095$64K0.0%-61.6%0.017%Search for SEC Filing on Google Icon
10/25/2023Zurcher Kantonalbank Zurich Cantonalbank6,542$59K0.0%+1,331.5%0.015%Search for SEC Filing on Google Icon
10/24/2023Bank of New York Mellon Corp97,159$0.88M0.0%+11.5%0.227%Search for SEC Filing on Google Icon
10/20/2023Harbor Capital Advisors Inc.10,266$93K0.0%-26.1%0.024%Search for SEC Filing on Google Icon
10/18/2023Exchange Traded Concepts LLC10,507$95K0.0%-9.9%0.025%Search for SEC Filing on Google Icon
10/13/2023SG Americas Securities LLC12,862$0.12M0.0%N/A0.030%Search for SEC Filing on Google Icon
8/22/2023CHI Advisors LLC3,414,189$36.74M11.1%+1.9%7.988%Search for SEC Filing on Google Icon
8/15/2023Braidwell LP1,908,865$20.54M0.7%N/A4.466%Search for SEC Filing on Google Icon
8/11/2023SVB Financial Group13,516$0.15M0.3%-33.3%0.034%Search for SEC Filing on Google Icon
8/11/2023Velan Capital Investment Management LP50,000$0.54M0.5%N/A0.127%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Cullinan Therapeutics logo
Cullinan Therapeutics, Inc., a biopharmaceutical company, focuses on developing oncology therapies for cancer patients in the United States. The company's lead program comprises CLN-619, a monoclonal antibody that is in Phase I clinical trial for the treatment of solid tumors. Its development portfolio also includes CLN-049, a humanized bispecific antibody that is in Phase I clinical trial for the treatment of acute myeloid leukemia or myelodysplastic syndrome; CLN-418, a human bispecific immune activator that is in Phase 1 clinical trial for the treatment of multiple solid tumors; and Zipalertinib, a bioavailable small-molecule for treating patients with non-small cell lung cancer. In addition, the company's development products comprise CLN-617, a fusion protein for the treatment of solid tumors; and CLN-978, a T cell engaging antibody for the treatment relapsed/refractory B-cell non-Hodgkin lymphoma. It has license and collaboration agreement with Adimab, LLC to discover and/or optimize antibodies; Harbour BioMed US Inc. for the development, manufacturing, and commercialization of CLN-418; and co-development agreement with Taiho Pharmaceutical Co., Ltd to develop Zipalertinib. Cullinan Therapeutics, Inc. was formerly known as Cullinan Oncology, Inc. and changed its name to Cullinan Therapeutics, Inc. in April 2024. Cullinan Therapeutics, Inc. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.
Read More on Cullinan Therapeutics

Today's Range

Now: $11.85
Low: $11.50
High: $12.06

50 Day Range

MA: $14.75
Low: $11.75
High: $17.61

52 Week Range

Now: $11.85
Low: $8.02
High: $30.19

Volume

107,702 shs

Average Volume

643,082 shs

Market Capitalization

$690.00 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Cullinan Therapeutics?

Cullinan Therapeutics' top insider investors include:
  1. Corrine Savill (Insider)
  2. Jennifer Michaelson (Insider)
  3. Nadim Ahmed (CEO)
  4. Jeffrey Trigilio (CFO)
  5. Jeffrey Alan Jones (Insider)
Learn More about top insider investors at Cullinan Therapeutics.

Who are the major institutional investors of Cullinan Therapeutics?

Cullinan Therapeutics' top institutional investors include:
  1. State Street Corp — 4.01%
  2. Franklin Resources Inc. — 3.76%
  3. RTW Investments LP — 2.93%
  4. Holocene Advisors LP — 2.63%
  5. Geode Capital Management LLC — 2.08%
  6. Braidwell LP — 2.02%
Learn More about top institutional investors of Cullinan Therapeutics stock.

Which institutional investors are selling Cullinan Therapeutics stock?

During the last quarter, CGEM stock was sold by these institutional investors:
  1. Franklin Resources Inc.
  2. PFM Health Sciences LP
  3. SG Americas Securities LLC
  4. Exchange Traded Concepts LLC
In the last year, company insiders that have sold Cullinan Therapeutics company stock include:
  1. Corrine Savill (Insider)
  2. Jennifer Michaelson (Insider)
  3. Nadim Ahmed (CEO)
  4. Jeffrey Trigilio (CFO)
  5. Jeffrey Alan Jones (Insider)
Learn More investors selling Cullinan Therapeutics stock.

Which institutional investors are buying Cullinan Therapeutics stock?

During the last quarter, CGEM stock was bought by institutional investors including:
  1. Braidwell LP
  2. Patient Square Capital LP
  3. RTW Investments LP
  4. State Street Corp
  5. Walleye Capital LLC
  6. Geode Capital Management LLC
  7. Holocene Advisors LP
  8. Sphera Funds Management LTD.